HCA Insider Trading
HCA Healthcare, Inc. | Services-General Medical & Surgical Hospitals, NEC
Comprehensive Trading Performance Summary
The investment history of corporate insiders at HCA Healthcare, Inc. provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Services-General Medical & Surgical Hospitals, NEC sector.
Transactions on Chart
Open Full Chart| Filing Date | Trade Date | Reporting Person | Relationship | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|
| 2021-02-11 03:14 | 2021-02-08 | Foster Jon M | Officer - Group President | SELL | $176.44 | 6,171 | $1,088,811 | 0 | -100.0% |
| 2021-02-06 04:32 | 2021-02-04 | Whalen Kathleen M | Officer - SVP & Chief Ethics Officer | OPT+S | $177.11 | 280 | $49,591 | 3,684 | 0.0% |
| 2021-02-06 04:31 | 2021-02-03 | Torres Kathryn A. | Officer - SVP-Payer Contracting & Align. | OPT+S | $174.86 | 5,066 | $885,862 | 11,980 | 0.0% |
| 2021-02-06 04:25 | 2021-02-03 | Cuffe Michael S. | Officer - President-Physician Services | OPT+S | $174.42 | 21,292 | $3,713,849 | 28,257 | 0.0% |
| 2021-02-06 04:33 | 2021-02-03 | Riley Wayne Joseph | Director | SELL | $170.60 | 3,300 | $562,964 | 12,469 | -20.9% |
| 2021-02-06 04:32 | 2021-02-05 | WATERMAN ROBERT A | Officer - SVP & General Counsel | OPT+S | $177.38 | 62,936 | $11,163,342 | 344,099 | 0.0% |
| 2021-02-06 04:27 | 2021-02-05 | MOORE A BRUCE JR | Officer - Group President - Service Line | OPT+S | $179.93 | 10,000 | $1,799,300 | 105,778 | 0.0% |
| 2020-11-28 01:12 | 2020-11-24 | Reiner Deborah M | Officer - SVP - Mktg. & Communications | SELL | $155.00 | 1,266 | $196,230 | 5,484 | -18.8% |
| 2020-11-18 04:21 | 2020-11-16 | Reiner Deborah M | Officer - SVP - Mktg. & Communications | SELL | $151.75 | 5,078 | $770,587 | 5,484 | -48.1% |
| 2020-11-18 04:18 | 2020-11-13 | Morrow J William | Officer - SVP - Finance and Treasurer | SELL | $151.46 | 9,218 | $1,396,132 | 1,358 | -87.2% |
| 2020-11-18 04:20 | 2020-11-13 | Paslick P. Martin | Officer - SVP and CIO | SELL | $151.57 | 4,089 | $619,778 | 0 | -100.0% |
| 2020-11-18 04:20 | 2020-11-13 | Perlin Jonathan B | Officer - Pres-Clinical Operations & CMO | OPT+S | $149.50 | 17,002 | $2,541,799 | 1,928 | 0.0% |
| 2020-11-13 04:40 | 2020-11-10 | Hall Charles J | Officer - Group President | SELL | $154.46 | 6,536 | $1,009,537 | 200,517 | -3.2% |
| 2020-11-10 05:08 | 2020-11-05 | Berres Jennifer | Officer - SVP & Chief Human Res. Officer | SELL | $139.19 | 3,472 | $483,258 | 1,375 | -71.6% |
| 2020-11-10 05:08 | 2020-11-05 | Englebright Jane D. | Officer - SVP and Chief Nursing Officer | SELL | $146.33 | 5,235 | $766,055 | 3,509 | -59.9% |
| 2020-11-10 05:11 | 2020-11-09 | Paslick P. Martin | Officer - SVP and CIO | OPT+S | $148.07 | 3,948 | $584,583 | 0 | 0.0% |
| 2020-11-10 05:10 | 2020-11-05 | Hall Charles J | Officer - Group President | SELL | $139.36 | 15,000 | $2,090,426 | 215,203 | -6.5% |
| 2020-11-10 05:11 | 2020-11-09 | Perlin Jonathan B | Officer - Pres-Clinical Operations & CMO | OPT+S | $147.36 | 5,531 | $815,070 | 17,532 | 0.0% |
| 2020-11-06 03:54 | 2020-11-03 | Paslick P. Martin | Officer - SVP and CIO | SELL | $133.50 | 1,771 | $236,429 | 0 | -100.0% |
| 2020-11-06 03:53 | 2020-11-05 | RUTHERFORD BILL B | Officer - CFO and EVP | OPT+S | $139.33 | 36,250 | $5,050,676 | 18,659 | 0.0% |
| 2020-11-06 03:52 | 2020-11-03 | HAZEN SAMUEL N | Officer - CEO | OPT+S | $135.61 | 121,875 | $16,527,834 | 268,476 | 0.0% |
| 2020-11-05 02:28 | 2020-11-02 | Morgan Sandra L. | Officer - SVP-Provider Relations | SELL | $127.75 | 5,030 | $642,564 | 5,598 | -47.3% |
| 2020-11-03 03:59 | 2020-10-29 | Whalen Kathleen M | Officer - SVP & Chief Ethics Officer | SELL | $124.41 | 1,268 | $157,747 | 3,964 | -24.2% |
| 2020-10-30 03:35 | 2020-10-27 | Morrow J William | Officer - SVP - Finance and Treasurer | OPT+S | $134.24 | 3,840 | $515,493 | 1,764 | 0.0% |
| 2020-10-30 03:35 | 2020-10-27 | Paslick P. Martin | Officer - SVP and CIO | SELL | $133.50 | 850 | $113,475 | 1,771 | -32.4% |
| 2020-08-14 01:52 | 2020-08-11 | Englebright Jane D. | Officer - SVP and Chief Nursing Officer | SELL | $132.71 | 5,245 | $696,059 | 8,744 | -37.5% |
| 2020-08-14 01:55 | 2020-08-11 | Paslick P. Martin | Officer - SVP and CIO | SELL | $134.97 | 227 | $30,638 | 2,621 | -8.0% |
| 2020-08-14 01:54 | 2020-08-11 | MOORE A BRUCE JR | Officer - Group President - Service Line | SELL | $133.73 | 15,000 | $2,005,965 | 88,626 | -14.5% |
| 2020-08-11 02:06 | 2020-08-06 | Paslick P. Martin | Officer - SVP and CIO | SELL | $132.97 | 2,848 | $378,699 | 2,848 | -50.0% |
| 2020-05-09 02:48 | 2020-05-06 | Foster Jon M | Officer - Group President | SELL | $100.19 | 24,220 | $2,426,655 | 40,203 | -37.6% |
| 2020-02-22 03:06 | 2020-02-19 | Paslick P. Martin | Officer - SVP and CIO | SELL | $150.00 | 5,167 | $775,050 | 5,696 | -47.6% |
| 2020-02-15 01:06 | 2020-02-12 | Reiner Deborah M | Officer - SVP - Mktg. & Communications | SELL | $150.12 | 2,050 | $307,746 | 5,484 | -27.2% |
| 2020-02-12 01:53 | 2020-02-07 | Whalen Kathleen M | Officer - SVP & Chief Ethics Officer | SELL | $146.46 | 1,956 | $286,475 | 3,964 | -33.0% |
| 2020-02-08 04:34 | 2020-02-05 | Torres Kathryn A. | Officer - SVP-Payer Contracting & Align. | SELL | $149.16 | 1,500 | $223,743 | 6,977 | -17.7% |
| 2020-02-08 04:26 | 2020-02-05 | Cuffe Michael S. | Officer - President-Physician Services | SELL | $150.00 | 6,459 | $968,850 | 28,734 | -18.4% |
| 2020-02-08 04:27 | 2020-02-05 | Englebright Jane D. | Officer - SVP and Chief Nursing Officer | SELL | $150.00 | 2,063 | $309,450 | 10,480 | -16.4% |
| 2020-02-07 02:43 | 2020-02-04 | Sowell Joseph A III | Officer - SVP; Chief Development Officer | SELL | $145.00 | 21,309 | $3,089,805 | 646 | -97.1% |
| 2020-02-01 03:46 | 2020-01-29 | Sowell Joseph A III | Officer - SVP; Chief Development Officer | OPT+S | $145.30 | 31,063 | $4,513,488 | 646 | 0.0% |
| 2019-12-27 01:02 | 2019-12-24 | Paslick P. Martin | Officer - SVP and CIO | OPT+S | $148.56 | 4,164 | $618,604 | 0 | 0.0% |
| 2019-12-24 00:52 | 2019-12-23 | Cuffe Michael S. | Officer - President-Physician Services | OPT+S | $147.04 | 5,891 | $866,213 | 35,193 | 0.0% |
| 2019-12-13 01:05 | 2019-12-11 | Englebright Jane D. | Officer - SVP and Chief Nursing Officer | SELL | $143.50 | 2,049 | $294,032 | 10,480 | -16.4% |
| 2019-11-13 02:54 | 2019-11-08 | Englebright Jane D. | Officer - SVP and Chief Nursing Officer | SELL | $137.50 | 1,995 | $274,313 | 10,480 | -16.0% |
| 2019-11-07 01:36 | 2019-11-04 | Whalen Kathleen M | Officer - SVP & Chief Ethics Officer | SELL | $135.21 | 2,540 | $343,438 | 5,920 | -30.0% |
| 2019-11-06 02:54 | 2019-11-05 | Reiner Deborah M | Officer - SVP - Mktg. & Communications | OPT+S | $136.67 | 749 | $102,366 | 5,484 | 0.0% |
| 2019-11-06 02:52 | 2019-11-01 | MOORE A BRUCE JR | Officer - Group President - Service Line | SELL | $135.07 | 15,000 | $2,026,095 | 224,585 | -6.3% |
| 2019-11-05 02:27 | 2019-10-31 | Foster Jon M | Officer - Group President | SELL | $132.35 | 19,477 | $2,577,707 | 10,015 | -66.0% |
| 2019-11-02 00:24 | 2019-10-30 | Wyatt Christopher F. | Officer - SVP & Controller | OPT+S | $134.74 | 3,900 | $525,487 | 17,251 | 0.0% |
| 2019-11-02 00:19 | 2019-10-30 | Morgan Sandra L. | Officer - SVP-Provider Relations | SELL | $133.87 | 3,482 | $466,142 | 7,121 | -32.8% |
| 2019-08-15 23:40 | 2019-08-13 | Whalen Kathleen M | Officer - SVP & Chief Ethics Officer | OPT+S | $127.56 | 977 | $124,626 | 8,460 | 0.0% |
| 2019-08-09 02:59 | 2019-08-06 | Elcan Patricia F | 10% owner | BUY | $124.10 | 250 | $31,024 | 997,017 | +0.0% |
How to Interpret $HCA Trades
Not every insider transaction in HCA Healthcare, Inc. is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $HCA shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.
Data Source & Accuracy for HCA
Insider activity data for HCA Healthcare, Inc. is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $HCA, allowing you to follow the capital of those with the most intimate knowledge of the company.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.